On Monday, Shares of Exxon Mobil Corporation (NYSE:XOM), lost -0.57% to $86.85.
Exxon Mobil Corporation, is holding its annual meeting of shareholders on Wednesday, May 27, 2015. Media access will be offered to authorized representatives of commercial news organizations who pre-register by Friday, May 22, 2015. Please note, only media which have pre-registered will be offered access to the annual meeting.
The meeting will be held at the Morton H. Meyerson Symphony Center, 2301 Flora Street, Dallas, Texas 75201 and will start at 9:30 a.m. CDT. Registered media will be offered access after 9 a.m.
Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania.
Shares of Medtronic plc (NYSE:MDT), inclined 1.37% to $77.47, during its last trading session.
Medtronic, declared study results demonstrating that its quadripolar cardiac resynchronization therapy (CRT) system gives physicians more options to optimize CRT delivery, which may improve heart failure patients` response to the therapy. During Heart Rhythm 2015, the Heart Rhythm Society`s 36th Annual Scientific Sessions in Boston, data from the Attain® Performa® Quadripolar Lead Clinical Study revealed the clinical benefits associated with steroid on all four electrodes. A separate analysis demonstrated the importance of assessing pacing vectors over time. VectorExpress(TM) technology, an easy-to-use tool found on Medtronic Viva® Quad CRT-defibrillators, provides clinically actionable information to assist physicians select and maintain the optimal pacing configurations - at implant and in follow-up visits - for each patient, in only two minutes.
“When physicians pair Attain Performa leads with Viva Quad devices and the AdaptivCRT technology to treat their heart failure patients, they have more options to optimize therapy delivery and personalize treatment,” said David Steinhaus, M.D., vice president and general manager, Heart Failure, and medical director for the Cardiac Rhythm and Heart Failure business, which is part of the Cardiac and Vascular Group at Medtronic. “These new data support the clinical benefits of CRT technology and add to the body of evidence supporting Medtronic quadripolar leads and CRT devices as an important therapy option for patients with heart failure.”
Medtronic plc, a healthcare solutions company, provides medical technologies, services, and solutions worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group.
At the end of Monday’s trade, Shares of The Blackstone Group L.P. (NYSE:BX), gained 1.31% to $43.96, hitting its highest level.
The Blackstone Group, declared recently that Steve Plavin, President and Chief Executive Officer, will present at the Keefe, Bruyette & Woods 2015 Mortgage Finance Conference in New York, New York on Tuesday, June 2, 2015 at 10:55 am EST.
The Blackstone Group L.P. is a publicly owned investment manager. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations.
Finally, United Continental Holdings, Inc. (NYSE:UAL), ended its last trade with 1.06% gain, and closed at $62.25.
United Continental Holdings, will present at the Wolfe Research 8th Annual Global Transportation Conference on Tuesday, May 19. The presentation will start at 7:00 a.m. CDT / 8:00 a.m. EDT.
United Continental Holdings, Inc., together with its auxiliaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. It transports people and cargo through its mainline operations, which use jet aircraft with at least 118 seats, and its regional operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
